收藏切换
The research on the value framework of Chinese patent medicine
收藏切换
Hai-xia DANG1, Jun LIU1, Bing LI1, Rong-li YOU1, Bing-wei CHEN2, Qi-guang CHEN2, Chun-di SHEN3, Zhong WANG1
Chinese Journal of New Drugs | 2021, 30(11) : 961 - 970
Less
收藏切换
Chinese Journal of New Drugs | 2021, 30(11): 961-970
The research on the value framework of Chinese patent medicine
Full
Hai-xia DANG1, Jun LIU1, Bing LI1, Rong-li YOU1, Bing-wei CHEN2, Qi-guang CHEN2, Chun-di SHEN3, Zhong WANG1
Affiliations
  • 1Institute of Basic Clinical Medicine, China Academy of Chinese Medical Science, Beijing 100700; China
  • 2Dongnan University, Nanjing 210096 China
  • 3Nanjing University of Chinese Medicine, Nanjing 210023, China
Published: 2021-06-15
Outline
收藏切换

Chinese patent medicine is one of important parts in Chinese drug market. It is imperative for new drug development and drug policy-making to establish a drug value assessment framework of Chinese patent medicine embodying the characteristics of traditional Chinese medicine. In this study, PubMed, CNKI and other domestic and foreign literature databases as well as the major international government and academic websites were searched to collect literature, policies, standards, guidelines and expert opinions related to drug value assessment at home and abroad. The methods of literature analysis, content analysis and expert consultation were comprehensively adopted to interpret, compare and analyze the relevant laws and regulations. We obtained the core elements and index system of drug value assessment in the world. According to the characteristics of Chinese medicine and the extensive expert consensus, a set of value assessment framework of Chinese patent medicine covering the whole life cycle from the establishment of the R&D project, pre-clinical application, new drug certificate application and post-marketing use is established, providing strong support for the research and development of new Chinese medicine, post marketing re-evaluation, establishment of clinical medication guidelines, drugs pricing, medical insurance compensation and medication choice of patients.

Chinese patent medicine  /  value assessment  /  indicator system
党海霞, 刘骏, 李兵, 游蓉丽, 陈炳为, 陈启光, 申春悌, 王忠. 中成药价值评估指标体系研究. 中国新药杂志, 2021 , 30 (11) : 961 -970 .
Hai-xia DANG, Jun LIU, Bing LI, Rong-li YOU, Bing-wei CHEN, Qi-guang CHEN, Chun-di SHEN, Zhong WANG. The research on the value framework of Chinese patent medicine[J]. Chinese Journal of New Drugs, 2021 , 30 (11) : 961 -970 .
Year 2021 volume 30 Issue 11
47
9
Cite this Article
BibTeX
Article Info
  • Online Date:2026-10-28
  • Published:2021-06-15
Article Data
Affiliations
History
  • Accepted:2020-11-16
Funding
Affiliations
    1Institute of Basic Clinical Medicine, China Academy of Chinese Medical Science, Beijing 100700; China
    2Dongnan University, Nanjing 210096 China
    3Nanjing University of Chinese Medicine, Nanjing 210023, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT